Navigation Links
Lotus Pharmaceuticals, Inc. to Exhibit at the 2009 International Conference for Bioeconomy
Date:6/17/2009

BEIJING, June 17 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical products in the People's Republic China, today reported it will exhibit at the main Medicine Hall at the 2009 International Conference for Bioeconomy to be held from June 26 to June 28 in Tianjin, China.

About the 2009 International Conference for Bioeconomy-the 44th New Drugs Expo

The 2009 International Conference for Bioeconomy, sponsored by Ministry of Science and Technology, State Food and Drug Administration, and the Tianjin Municipal Government, is aimed to tackle financial crisis with the development of bio-economy. It provides a platform for marketing, networking, strategic partnership and information exchange. It is one of the largest and most reputable biotech and new drugs conferences in China. About 3,000 domestic and foreign companies are expected to be present at the exhibition. Eleven breakout sessions will be held to discuss frontier bio-technologies applied in life sciences, medicine, agriculture, energy, resources, environment and etc. For more information, please visit http://www.bioeco.net.cn .

About Lotus Pharmaceuticals, Inc. ( http://www.lotuspharma.com )

Lotus Pharmaceuticals, Inc. is a growing developer and producer of prescription drugs and a licensed national seller of pharmaceutical items in the People's Republic of China. Lotus operates Liang Fang Pharmaceutical, Ltd. and En Ze Jia Shi Pharmaceutical, Ltd. Lotus's current drug development pipeline is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes. More than 8,000 products are sold by Liang Fang directly and indirectly through its national sales channels to hospitals, clinics and drugs stores in 30 provinces.

    For more information, please contact:

    Lotus Pharmaceuticals, Inc.
     Yan Zeng, CFO
     Phone:  +8610-6389-9868
     Email: zy@lotuspharma.com
     Web:  http://www.lotuspharma.com

'/>"/>
SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
2. Lotus Pharmaceuticals, Inc. Reports Strong 2008 Financial Results
3. iEnterprises Launches iComply, Lotus Notes Email Archiving and Compliance Software
4. Lotus Pharmaceuticals, Inc. Purchases Intellectual Property Rights to an Established Prescription Drug
5. Lotus Pharmaceuticals, Inc. Purchases Land Use Rights to Grow its Business and Reduce Costs
6. Lotus Pharmaceuticals to Present at Rodman & Renshaw Conference
7. Lotus Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2008 Results
8. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
9. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results
10. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
11. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... 2017   Montrium , an industry leader ... the IQPC Trial Master Files & Inspection Readiness ... EastHORN Clinical Services has selected eTMF Connect ... management. EastHORN, a leading European contract research organization ... transparency to enable greater collaboration with sponsors, improve ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: